{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:29:28Z","timestamp":1793042968019,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Gusu School, Nanjing Medical University","award":["GSRCKY20210203"],"award-info":[{"award-number":["GSRCKY20210203"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070438"],"award-info":[{"award-number":["82070438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alamandine (Ala) is the newest identified peptide of the renin-angiotensin system and has protective effect on myocyte hypertrophy. However, it is still unclear whether Ala can alleviate heart failure (HF). The aim of this study was to explore the effects of Ala on HF and the related cardiac fibrosis, and to probe the mechanism. HF model was induced by myocardial infarction (MI) in mice. Four weeks after MI, Ala was administrated by intraperitoneal injection for two weeks. Ala injection significantly improved cardiac dysfunction of MI mice in vivo. The cardiac fibrosis and the related biomarkers were attenuated after Ala administration in HF mice in vivo. The increases of collagen I, alpha-smooth muscle actin and transforming growth factor-beta induced by oxygen\u2013glucose deprivation (OGD) in neonatal rat cardiac fibroblasts (NRCFs) were inhibited by Ala treatment in vitro. The biomarkers of apoptosis were elevated in NRCFs induced by OGD, which were attenuated after treating with Ala in vitro. The enhancement of oxidative stress in the heart of MI mice or in the NRCFs treated with OGD was suppressed by treating with Ala in vivo and in vitro. These effects of Ala were reversed by tBHP, an exogenous inducer of oxidative stress in vitro. These results demonstrated that Ala could alleviate cardiac dysfunction and attenuate cardiac fibrosis via inhibition of oxidative stress.<\/jats:p>","DOI":"10.1186\/s13062-022-00338-6","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T14:03:59Z","timestamp":1664287439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Alamandine alleviated heart failure and fibrosis in myocardial infarction mice"],"prefix":"10.1186","volume":"17","author":[{"given":"Kun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"338_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-021-27637-2","volume":"13","author":"P Lagonegro","year":"2022","unstructured":"Lagonegro P, Rossi S, Salvarani N, et al. Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires. Nat Commun. 2022;13:6.","journal-title":"Nat Commun"},{"key":"338_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174932","volume":"923","author":"K Zhao","year":"2022","unstructured":"Zhao K, Li Y, Zhou Z, et al. Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation. Eur J Pharmacol. 2022;923: 174932.","journal-title":"Eur J Pharmacol"},{"key":"338_CR3","first-page":"e391","volume":"119","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:e391-479.","journal-title":"Circulation"},{"key":"338_CR4","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/ijerph7041807","volume":"7","author":"VL Roger","year":"2010","unstructured":"Roger VL. The heart failure epidemic. Int J Environ Res Public Health. 2010;7:1807\u201330.","journal-title":"Int J Environ Res Public Health"},{"key":"338_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173961","volume":"897","author":"PA Nicolaou","year":"2021","unstructured":"Nicolaou PA. Sex differences in heart failure medications targeting the renin-angiotensin-aldosterone system. Eur J Pharmacol. 2021;897: 173961.","journal-title":"Eur J Pharmacol"},{"key":"338_CR6","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.3390\/ijms222312800","volume":"22","author":"T Rajtik","year":"2021","unstructured":"Rajtik T, Galis P, Bartosova L, Paulis L, Goncalvesova E, Klimas J. Alternative RAS in various hypoxic conditions: from myocardial infarction to COVID-19. Int J Mol Sci. 2021;22:12800.","journal-title":"Int J Mol Sci"},{"key":"338_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","volume":"118","author":"VB Patel","year":"2016","unstructured":"Patel VB, Zhong JC, Grant MB, Oudit GY. Role of the ACE2\/angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure. Circ Res. 2016;118:1313\u201326.","journal-title":"Circ Res"},{"key":"338_CR8","first-page":"1145","volume":"4","author":"X Liao","year":"2011","unstructured":"Liao X, Wang L, Yang C, et al. Cyclooxygenase mediates cardioprotection of angiotensin-(1-7) against ischemia\/reperfusion-induced injury through the inhibition of oxidative stress. Mol Med Rep. 2011;4:1145\u201350.","journal-title":"Mol Med Rep"},{"key":"338_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170612","volume":"144","author":"H Xu","year":"2021","unstructured":"Xu H, An X, Tian J, et al. Angiotensin-(1-7) protects against sepsis-associated left ventricular dysfunction induced by lipopolysaccharide. Peptides. 2021;144: 170612.","journal-title":"Peptides"},{"key":"338_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/08977194.2016.1155150","volume":"34","author":"RL Chang","year":"2016","unstructured":"Chang RL, Lin JW, Kuo WW, et al. Angiotensin-(1-7) attenuated long-term hypoxia-stimulated cardiomyocyte apoptosis by inhibiting HIF-1\u03b1 nuclear translocation via Mas receptor regulation. Growth Factors. 2016;34:11\u20138.","journal-title":"Growth Factors"},{"key":"338_CR11","first-page":"125","volume":"3","author":"C Schindler","year":"2007","unstructured":"Schindler C, Bramlage P, Kirch W, Ferrario CM. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag. 2007;3:125\u201337.","journal-title":"Vasc Health Risk Manag"},{"key":"338_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","volume":"112","author":"RQ Lautner","year":"2013","unstructured":"Lautner RQ, Villela DC, Fraga-Silva RA, et al. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res. 2013;112:1104\u201311.","journal-title":"Circ Res"},{"key":"338_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/01.mnh.0000441052.44406.92","volume":"23","author":"DC Villela","year":"2014","unstructured":"Villela DC, Passos-Silva DG, Santos RA. Alamandine: a new member of the angiotensin family. Curr Opin Nephrol Hypertens. 2014;23:130\u20134.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"338_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00726-018-2583-x","volume":"50","author":"C Liu","year":"2018","unstructured":"Liu C, Yang CX, Chen XR, et al. Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats. Amino Acids. 2018;50:1071\u201381.","journal-title":"Amino Acids"},{"key":"338_CR15","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","volume":"88","author":"HA Rockman","year":"1991","unstructured":"Rockman HA, Ross RS, Harris AN, et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA. 1991;88:8277\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"338_CR16","doi-asserted-by":"publisher","first-page":"C702","DOI":"10.1152\/ajpcell.00153.2017","volume":"314","author":"ICG Jesus","year":"2018","unstructured":"Jesus ICG, Scalzo S, Alves F, et al. Alamandine acts via MrgD to induce AMPK\/NO activation against ANG II hypertrophy in cardiomyocytes. Am J Physiol Cell Physiol. 2018;314:C702-c711.","journal-title":"Am J Physiol Cell Physiol"},{"key":"338_CR17","doi-asserted-by":"publisher","first-page":"H352","DOI":"10.1152\/ajpheart.00328.2020","volume":"320","author":"MM Silva","year":"2021","unstructured":"Silva MM, de Souza-Neto FP, Jesus ICG, et al. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice. Am J Physiol Heart Circ Physiol. 2021;320:H352-h363.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"338_CR18","first-page":"6718","volume":"23","author":"XD Song","year":"2019","unstructured":"Song XD, Feng JP, Yang RX. Alamandine protects rat from myocardial ischemia-reperfusion injury by activating JNK and inhibiting NF-\u03baB. Eur Rev Med Pharmacol Sci. 2019;23:6718\u201326.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"338_CR19","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1161\/01.CIR.96.7.2414","volume":"96","author":"MF Hill","year":"1997","unstructured":"Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation. 1997;96:2414\u201320.","journal-title":"Circulation"},{"key":"338_CR20","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.yjmcc.2012.02.007","volume":"52","author":"X Wang","year":"2012","unstructured":"Wang X, Jian C, Zhang X, et al. Superoxide flashes: elemental events of mitochondrial ROS signaling in the heart. J Mol Cell Cardiol. 2012;52:940\u20138.","journal-title":"J Mol Cell Cardiol"},{"key":"338_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","volume":"49","author":"E Takimoto","year":"2007","unstructured":"Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension. 2007;49:241\u20138.","journal-title":"Hypertension"},{"key":"338_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/hrt.65.5.245","volume":"65","author":"JJ Belch","year":"1991","unstructured":"Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65:245\u20138.","journal-title":"Br Heart J"},{"key":"338_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.stem.2021.10.009","volume":"29","author":"V Janbandhu","year":"2022","unstructured":"Janbandhu V, Tallapragada V, Patrick R, et al. Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction. Cell Stem Cell. 2022;29:281-297.e212.","journal-title":"Cell Stem Cell"},{"key":"338_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1042\/CS20191235","volume":"134","author":"Y Huang","year":"2020","unstructured":"Huang Y, Li Y, Lou A, et al. Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS. Clin Sci (Lond). 2020;134:853\u201369.","journal-title":"Clin Sci (Lond)"},{"key":"338_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/jpp\/rgab091","volume":"73","author":"J Zhu","year":"2021","unstructured":"Zhu J, Qiu JG, Xu WT, Ma HX, Jiang K. Alamandine protects against renal ischaemia-reperfusion injury in rats via inhibiting oxidative stress. J Pharm Pharmacol. 2021;73:1491\u2013502.","journal-title":"J Pharm Pharmacol"},{"key":"338_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12933-020-01066-9","volume":"19","author":"S Lahnwong","year":"2020","unstructured":"Lahnwong S, Palee S, Apaijai N, et al. Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia\/reperfusion injury. Cardiovasc Diabetol. 2020;19:91.","journal-title":"Cardiovasc Diabetol"},{"key":"338_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1755-5922.12210","volume":"34","author":"S Thummasorn","year":"2016","unstructured":"Thummasorn S, Apaijai N, Kerdphoo S, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N. Humanin exerts cardioprotection against cardiac ischemia\/reperfusion injury through attenuation of mitochondrial dysfunction. Cardiovasc Ther. 2016;34:404\u201314.","journal-title":"Cardiovasc Ther"},{"key":"338_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.lfs.2018.04.010","volume":"206","author":"P Li","year":"2018","unstructured":"Li P, Chen XR, Xu F, et al. Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways. Life Sci. 2018;206:106\u201316.","journal-title":"Life Sci"},{"key":"338_CR29","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/jnr.23204","volume":"91","author":"SS Karuppagounder","year":"2013","unstructured":"Karuppagounder SS, Basso M, Sleiman SF, et al. In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1\u03b1 by inhibition of synthesis and not enhanced degradation. J Neurosci Res. 2013;91:1066\u201375.","journal-title":"J Neurosci Res"},{"key":"338_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbadis.2013.02.004","volume":"1832","author":"R Vivar","year":"2013","unstructured":"Vivar R, Humeres C, Ayala P, et al. TGF-\u03b21 prevents simulated ischemia\/reperfusion-induced cardiac fibroblast apoptosis by activation of both canonical and non-canonical signaling pathways. Biochim Biophys Acta. 2013;1832:754\u201362.","journal-title":"Biochim Biophys Acta"},{"key":"338_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biopha.2015.04.017","volume":"72","author":"SK Dash","year":"2015","unstructured":"Dash SK, Chattopadhyay S, Ghosh T, et al. Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-\u03b1-caspase-3 activity. Biomed Pharmacother. 2015;72:144\u201357.","journal-title":"Biomed Pharmacother"},{"key":"338_CR32","doi-asserted-by":"publisher","first-page":"H2879","DOI":"10.1152\/ajpheart.91406.2007","volume":"294","author":"M Takahashi","year":"2008","unstructured":"Takahashi M, Suzuki E, Takeda R, et al. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species. Am J Physiol Heart Circ Physiol. 2008;294:H2879-2888.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"338_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","volume":"7","author":"SW van den Borne","year":"2010","unstructured":"van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010;7:30\u20137.","journal-title":"Nat Rev Cardiol"},{"key":"338_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1755-1536-6-5","volume":"6","author":"NA Turner","year":"2013","unstructured":"Turner NA, Porter KE. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair. 2013;6:5.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"338_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","volume":"123","author":"KE Porter","year":"2009","unstructured":"Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009;123:255\u201378.","journal-title":"Pharmacol Ther"},{"key":"338_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-61779-382-0_15","volume":"810","author":"R Wong","year":"2012","unstructured":"Wong R, Steenbergen C, Murphy E. Mitochondrial permeability transition pore and calcium handling. Methods Mol Biol. 2012;810:235\u201342.","journal-title":"Methods Mol Biol"},{"key":"338_CR37","first-page":"2597","volume":"8","author":"J Liu","year":"2016","unstructured":"Liu J, Yang S, Zhang X, Liu G, Yue X. Isoflurane reduces oxygen-glucose deprivation-induced oxidative, inflammatory, and apoptotic responses in H9c2 cardiomyocytes. Am J Transl Res. 2016;8:2597\u2013608.","journal-title":"Am J Transl Res"},{"key":"338_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/clpt.2013.136","volume":"94","author":"J P\u00f6ss","year":"2013","unstructured":"P\u00f6ss J, Link A, B\u00f6hm M. Pharmacological treatment of acute heart failure: current treatment and new targets. Clin Pharmacol Ther. 2013;94:499\u2013508.","journal-title":"Clin Pharmacol Ther"},{"key":"338_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1556\/650.2016.30579","volume":"157","author":"N Nyolczas","year":"2016","unstructured":"Nyolczas N. Novelties in the pharmacological treatment of chronic heart failure. Orv Hetil. 2016;157:1517\u201321.","journal-title":"Orv Hetil"},{"key":"338_CR40","first-page":"774","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38:774\u201384.","journal-title":"Eur Heart J"},{"key":"338_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ncpcardio0096","volume":"2","author":"RO Cannon 3rd","year":"2005","unstructured":"Cannon RO 3rd. Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction. Nat Clin Pract Cardiovasc Med. 2005;2:88\u201394.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"338_CR42","first-page":"H1040","volume":"271","author":"RC Passier","year":"1996","unstructured":"Passier RC, Smits JF, Verluyten MJ, Daemen MJ. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol. 1996;271:H1040-1048.","journal-title":"Am J Physiol"},{"key":"338_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1006\/jmcc.1996.0080","volume":"28","author":"Y Sun","year":"1996","unstructured":"Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol. 1996;28:851\u20138.","journal-title":"J Mol Cell Cardiol"},{"key":"338_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.yjmcc.2009.08.002","volume":"48","author":"Y Sun","year":"2010","unstructured":"Sun Y. Intracardiac renin-angiotensin system and myocardial repair\/remodeling following infarction. J Mol Cell Cardiol. 2010;48:483\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"338_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","volume":"94","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A, Khan H, Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017;94:317\u201325.","journal-title":"Biomed Pharmacother"},{"key":"338_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/01.hco.0000231394.79609.24","volume":"21","author":"M Tokmakova","year":"2006","unstructured":"Tokmakova M, Solomon SD. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials. Curr Opin Cardiol. 2006;21:268\u201372.","journal-title":"Curr Opin Cardiol"},{"key":"338_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrendo.2015.6","volume":"11","author":"CA Romero","year":"2015","unstructured":"Romero CA, Orias M, Weir MR. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol. 2015;11:242\u201352.","journal-title":"Nat Rev Endocrinol"},{"key":"338_CR48","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/cvr\/28.11.1623","volume":"28","author":"Y Sun","year":"1994","unstructured":"Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res. 1994;28:1623\u20138.","journal-title":"Cardiovasc Res"},{"key":"338_CR49","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11906-014-0441-0","volume":"16","author":"E Kaschina","year":"2014","unstructured":"Kaschina E, Lauer D, Schmerler P, Unger T, Steckelings UM. AT2 receptors targeting cardiac protection post-myocardial infarction. Curr Hypertens Rep. 2014;16:441.","journal-title":"Curr Hypertens Rep"},{"key":"338_CR50","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/01.HYP.0000048340.53100.43","volume":"41","author":"Y Oishi","year":"2003","unstructured":"Oishi Y, Ozono R, Yano Y, et al. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension. 2003;41:814\u20138.","journal-title":"Hypertension"},{"key":"338_CR51","doi-asserted-by":"publisher","first-page":"150s","DOI":"10.1016\/S0895-7061(99)00218-6","volume":"12","author":"O Chung","year":"1999","unstructured":"Chung O, Unger T. Angiotensin II receptor blockade and end-organ protection. Am J Hypertens. 1999;12:150s\u20136s.","journal-title":"Am J Hypertens"},{"key":"338_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00592-018-1220-1","volume":"56","author":"G Castoldi","year":"2019","unstructured":"Castoldi G, di Gioia CRT, Roma F, et al. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats. Acta Diabetol. 2019;56:97\u2013104.","journal-title":"Acta Diabetol"},{"key":"338_CR53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1089\/scd.2020.0132","volume":"30","author":"M Xiao","year":"2021","unstructured":"Xiao M, Zeng W, Wang J, et al. Exosomes protect against acute myocardial infarction in rats by regulating the renin-angiotensin system. Stem Cells Dev. 2021;30:622\u201331.","journal-title":"Stem Cells Dev"},{"key":"338_CR54","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3892\/mmr.2017.6848","volume":"16","author":"J Wang","year":"2017","unstructured":"Wang J, He W, Guo L, et al. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction. Mol Med Rep. 2017;16:1973\u201381.","journal-title":"Mol Med Rep"},{"key":"338_CR55","doi-asserted-by":"crossref","unstructured":"Chappell MC. (2019) The angiotensin-(1-7) axis: formation and metabolism pathways. Angiotensin-(1-7), pp 1\u201326","DOI":"10.1007\/978-3-030-22696-1_1"},{"key":"338_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11010-017-2958-4","volume":"430","author":"P Pachauri","year":"2017","unstructured":"Pachauri P, Garabadu D, Goyal A, Upadhyay PK. Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart. Mol Cell Biochem. 2017;430:99\u2013113.","journal-title":"Mol Cell Biochem"},{"key":"338_CR57","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jdi.12603","volume":"8","author":"Y Lei","year":"2017","unstructured":"Lei Y, Xu Q, Zeng B, et al. Angiotensin-(1-7) protects cardiomyocytes against high glucose-induced injuries through inhibiting reactive oxygen species-activated leptin-p38 mitogen-activated protein kinase\/extracellular signal-regulated protein kinase 1\/2 pathways, but not the leptin-c-Jun N-terminal kinase pathway in vitro. J Diabetes Investig. 2017;8:434\u201345.","journal-title":"J Diabetes Investig"},{"key":"338_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/FJC.0000000000000043","volume":"63","author":"L Wang","year":"2014","unstructured":"Wang L, Luo D, Liao X, et al. Ang-(1-7) offers cytoprotection against ischemia-reperfusion injury by restoring intracellular calcium homeostasis. J Cardiovasc Pharmacol. 2014;63:259\u201364.","journal-title":"J Cardiovasc Pharmacol"},{"key":"338_CR59","first-page":"219","volume":"40","author":"HZ Liu","year":"2012","unstructured":"Liu HZ, Gao CY, Wang XQ, et al. Angiotensin(1-7) attenuates left ventricular dysfunction and myocardial apoptosis on rat model of adriamycin-induced dilated cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40:219\u201324.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"338_CR60","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1161\/01.CIR.0000092888.63239.54","volume":"108","author":"DB Averill","year":"2003","unstructured":"Averill DB, Ishiyama Y, Chappell MC, Ferrario CM. Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation. 2003;108:2141\u20136.","journal-title":"Circulation"},{"key":"338_CR61","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.109.905968","volume":"3","author":"Y Wang","year":"2010","unstructured":"Wang Y, Qian C, Roks AJ, et al. Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circ Heart Fail. 2010;3:286\u201393.","journal-title":"Circ Heart Fail"},{"key":"338_CR62","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1113\/expphysiol.2011.056994","volume":"96","author":"Y Qi","year":"2011","unstructured":"Qi Y, Shenoy V, Wong F, et al. Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Exp Physiol. 2011;96:863\u201374.","journal-title":"Exp Physiol"},{"key":"338_CR63","doi-asserted-by":"publisher","first-page":"H1113","DOI":"10.1152\/ajpheart.00828.2006","volume":"292","author":"AJ Ferreira","year":"2007","unstructured":"Ferreira AJ, Jacoby BA, Ara\u00fajo CA, et al. The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. Am J Physiol Heart Circ Physiol. 2007;292:H1113-1119.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"338_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2019.103486","volume":"208","author":"DP G\u00f3mez-Mendoza","year":"2019","unstructured":"G\u00f3mez-Mendoza DP, Marques FD, Melo-Braga MN, et al. Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4. J Proteomics. 2019;208: 103486.","journal-title":"J Proteomics"},{"key":"338_CR65","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0008-6363(95)00232-4","volume":"31","author":"Y Sun","year":"1996","unstructured":"Sun Y, Weber KT. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res. 1996;31:518\u201325.","journal-title":"Cardiovasc Res"},{"key":"338_CR66","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cphy.c160006","volume":"7","author":"T Kalogeris","year":"2016","unstructured":"Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia\/reperfusion. Compr Physiol. 2016;7:113\u201370.","journal-title":"Compr Physiol"},{"key":"338_CR67","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1253\/circj.CJ-17-1381","volume":"82","author":"BM Park","year":"2018","unstructured":"Park BM, Phuong HTA, Yu L, Kim SH. Alamandine protects the heart against reperfusion injury via the MrgD receptor. Circ J. 2018;82:2584\u201393.","journal-title":"Circ J"},{"key":"338_CR68","doi-asserted-by":"publisher","first-page":"30k","DOI":"10.1016\/S0002-9149(98)00535-9","volume":"82","author":"J Kajstura","year":"1998","unstructured":"Kajstura J, Liu Y, Baldini A, et al. Coronary artery constriction in rats: necrotic and apoptotic myocyte death. Am J Cardiol. 1998;82:30k\u201341k.","journal-title":"Am J Cardiol"},{"key":"338_CR69","first-page":"H2313","volume":"272","author":"Z Li","year":"1997","unstructured":"Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 1997;272:H2313-2319.","journal-title":"Am J Physiol"},{"key":"338_CR70","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","volume":"453","author":"GC Gurtner","year":"2008","unstructured":"Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314\u201321.","journal-title":"Nature"},{"key":"338_CR71","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021\u201340.","journal-title":"Circ Res"},{"key":"338_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0735-1097(01)01709-0","volume":"39","author":"YT Sia","year":"2002","unstructured":"Sia YT, Parker TG, Liu P, Tsoporis JN, Adam A, Rouleau JL. Improved post-myocardial infarction survival with probucol in rats: effects on left ventricular function, morphology, cardiac oxidative stress and cytokine expression. J Am Coll Cardiol. 2002;39:148\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"338_CR73","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2147\/IJN.S240660","volume":"15","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang J. Exosomal lncRNA AK139128 derived from hypoxic cardiomyocytes promotes apoptosis and inhibits cell proliferation in cardiac fibroblasts. Int J Nanomed. 2020;15:3363\u201376.","journal-title":"Int J Nanomed"},{"key":"338_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113228","volume":"418","author":"Y Cao","year":"2022","unstructured":"Cao Y, Dong Z, Yang D, Ma X, Wang X. LSD1 regulates the expressions of core cardiogenic transcription factors and cardiac genes in oxygen and glucose deprivation injured mice fibroblasts in vitro. Exp Cell Res. 2022;418: 113228.","journal-title":"Exp Cell Res"},{"key":"338_CR75","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/00005344-200412000-00010","volume":"44","author":"K Chen","year":"2004","unstructured":"Chen K, Li D, Zhang X, Hermonat PL, Mehta JL. Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol. 2004;44:682\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"key":"338_CR76","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0022-2143(03)00148-3","volume":"142","author":"D Kumar","year":"2003","unstructured":"Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med. 2003;142:288\u201397.","journal-title":"J Lab Clin Med"},{"key":"338_CR77","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1161\/01.RES.85.5.403","volume":"85","author":"S Bialik","year":"1999","unstructured":"Bialik S, Cryns VL, Drincic A, et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res. 1999;85:403\u201314.","journal-title":"Circ Res"},{"key":"338_CR78","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/clinchem\/43.7.1209","volume":"43","author":"F Nielsen","year":"1997","unstructured":"Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem. 1997;43:1209\u201314.","journal-title":"Clin Chem"},{"key":"338_CR79","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","volume":"51","author":"K Sugamura","year":"2011","unstructured":"Sugamura K, Keaney JF Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2011;51:978\u201392.","journal-title":"Free Radic Biol Med"},{"key":"338_CR80","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4330\/wjc.v3.i6.186","volume":"3","author":"MG Perrelli","year":"2011","unstructured":"Perrelli MG, Pagliaro P, Penna C. Ischemia\/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol. 2011;3:186\u2013200.","journal-title":"World J Cardiol"},{"key":"338_CR81","doi-asserted-by":"publisher","first-page":"35028","DOI":"10.18632\/oncotarget.26164","volume":"9","author":"R Coluccia","year":"2018","unstructured":"Coluccia R, Raffa S, Ranieri D, et al. Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes. Oncotarget. 2018;9:35028\u201340.","journal-title":"Oncotarget"},{"key":"338_CR82","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 2011;301:H2181-2190.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"338_CR83","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/01.CIR.99.1.121","volume":"99","author":"VP Palace","year":"1999","unstructured":"Palace VP, Hill MF, Farahmand F, Singal PK. Mobilization of antioxidant vitamin pools and hemodynamic function after myocardial infarction. Circulation. 1999;99:121\u20136.","journal-title":"Circulation"},{"key":"338_CR84","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/09603271211010896","volume":"40","author":"AS Hekmat","year":"2021","unstructured":"Hekmat AS, Navabi Z, Alipanah H, Javanmardi K. Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol. 2021;40:1781\u201395.","journal-title":"Hum Exp Toxicol"},{"key":"338_CR85","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41598-020-59216-8","volume":"10","author":"H Wanka","year":"2020","unstructured":"Wanka H, Lutze P, Staar D, et al. Non-secretory renin reduces oxidative stress and increases cardiomyoblast survival during glucose and oxygen deprivation. Sci Rep. 2020;10:2329.","journal-title":"Sci Rep"},{"key":"338_CR86","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.3390\/ijms22136702","volume":"22","author":"AV Poznyak","year":"2021","unstructured":"Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD. Int J Mol Sci. 2021;22:6702.","journal-title":"Int J Mol Sci"},{"key":"338_CR87","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/hum.2009.160","volume":"21","author":"YX Zhao","year":"2010","unstructured":"Zhao YX, Yin HQ, Yu QT, et al. ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum Gene Ther. 2010;21:1545\u201354.","journal-title":"Hum Gene Ther"},{"key":"338_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2022.170746","volume":"151","author":"DCO Coutinho","year":"2022","unstructured":"Coutinho DCO, Santos-Miranda A, Joviano-Santos JV, et al. Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia\/reperfusion-induced cardiac injury. Peptides. 2022;151: 170746.","journal-title":"Peptides"},{"key":"338_CR89","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00259-020-04736-8","volume":"47","author":"T Borchert","year":"2020","unstructured":"Borchert T, Hess A, Luka\u010devi\u0107 M, Ross TL, Bengel FM, Thackeray JT. Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation. Eur J Nucl Med Mol Imaging. 2020;47:1757\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"338_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108660","volume":"114","author":"Y Ma","year":"2019","unstructured":"Ma Y, Yuan J, Hu J, Gao W, Zou Y, Ge J. ACE inhibitor suppresses cardiac remodeling after myocardial infarction by regulating dendritic cells and AT(2) receptor-mediated mechanism in mice. Biomed Pharmacother. 2019;114: 108660.","journal-title":"Biomed Pharmacother"},{"key":"338_CR91","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/01.HYP.32.3.496","volume":"32","author":"K Yamada","year":"1998","unstructured":"Yamada K, Iyer SN, Chappell MC, Ganten D, Ferrario CM. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension. 1998;32:496\u2013502.","journal-title":"Hypertension"},{"key":"338_CR92","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.1038\/s41598-017-12074-3","volume":"7","author":"LB Teixeira","year":"2017","unstructured":"Teixeira LB, Parreiras ESLT, Bruder-Nascimento T, et al. Ang-(1-7) is an endogenous \u03b2-arrestin-biased agonist of the AT(1) receptor with protective action in cardiac hypertrophy. Sci Rep. 2017;7:11903.","journal-title":"Sci Rep"},{"key":"338_CR93","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.phrs.2016.07.025","volume":"111","author":"T Qaradakhi","year":"2016","unstructured":"Qaradakhi T, Apostolopoulos V, Zulli A. Angiotensin (1-7) and alamandine: similarities and differences. Pharmacol Res. 2016;111:820\u20136.","journal-title":"Pharmacol Res"},{"key":"338_CR94","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","volume":"107","author":"ESAC Sim\u00f5es","year":"2016","unstructured":"Sim\u00f5es ESAC, Teixeira MM. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res. 2016;107:154\u201362.","journal-title":"Pharmacol Res"},{"key":"338_CR95","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","volume":"17","author":"M Paz Ocaranza","year":"2020","unstructured":"Paz Ocaranza M, Riquelme JA, Garc\u00eda L, et al. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17:116\u201329.","journal-title":"Nat Rev Cardiol"},{"key":"338_CR96","doi-asserted-by":"publisher","first-page":"R513","DOI":"10.1152\/ajpregu.00308.2020","volume":"321","author":"FR Marins","year":"2021","unstructured":"Marins FR, Oliveira AC, Qadri F, et al. Alamandine but not angiotensin-(1-7) produces cardiovascular effects at the rostral insular cortex. Am J Physiol Regul Integr Comp Physiol. 2021;321:R513-r521.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"338_CR97","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fmed.2019.00107","volume":"6","author":"J Schleifenbaum","year":"2019","unstructured":"Schleifenbaum J. Alamandine and its receptor MrgD pair up to join the protective arm of the renin-angiotensin system. Front Med (Lausanne). 2019;6:107.","journal-title":"Front Med (Lausanne)"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-022-00338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-022-00338-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-022-00338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T20:07:57Z","timestamp":1666469277000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-022-00338-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1186\/s13062-022-00338-6","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were approved by the Experimental Animal Care and Use Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}